BMA Welcomes HFEA Decision On Embryo Research, UK

Main Category: Biology / Biochemistry
Also Included In: Alzheimer's / Dementia;  Parkinson's Disease
Article Date: 06 Sep 2007 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:5 stars

5 (1 votes)


The Human Fertilisation and Embryology Authority (HFEA) approved the principle of human-animal embryos being used for medical research.

The BMA welcomes the decision: Dr Tony Calland, chairman of the BMA Medical Ethics Committee, says:

"This kind of research could lead to major breakthroughs in treatments for Alzheimer's, Parkinson's and other serious diseases.

"We understand people's initial resistance to the idea of hybrid embryos, but there would be very strict controls on the way they are used. The law already prevents such embryos being implanted in a woman, and they must be destroyed within 14 days. Individual research projects are highly regulated."

http://www.bma.org.uk

Article adapted by Medical News Today from original press release.
Visit our biology / biochemistry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
BMA. "BMA Welcomes HFEA Decision On Embryo Research, UK." Medical News Today. MediLexicon, Intl., 6 Sep. 2007. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/81589.php>

APA
BMA. (2007, September 6). "BMA Welcomes HFEA Decision On Embryo Research, UK." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/81589.php.

Please note: If no author information is provided, the source is cited instead.


Biology / Biochemistry

Most Popular Articles



Follow Our Biology News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Biology / Biochemistry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »